MiRNA Sequencing and Assay Market to Grow at a CAGR of 11.9% to reach US$ 468.99 Million from 2020 to 2027

    MiRNA Sequencing and Assay Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product (Library Preparation and Consumables), Technology (Sequencing By Synthesis, Nanopore, and Ion Semiconductor Sequencing), and End User (Research Institute, Academia, and CRO) By Geography

    Publication Month: Feb 2021 | Report Code: TIPRE00006960 | No. of Pages: 156 | Category: Biotechnology | Status: Published

    The microRNA (miRNA) sequencing and assay market is expected to reach US$ 468.99 million by 2027 from US$ 192.31 million in 2019; it is estimated to grow at a CAGR of 11.9% from 2020 to 2027.

    miRNA is a small non-coding RNA molecule of 20–30-nucleotide length, and it plays an important role in gene regulation. As it is partially complementary to messenger RNA (mRNA), it serves a major function of down-regulating the gene expression, which makes it a key controller of important cellular functions. miRNAs are associated with pathological processes such as viral infections, autoimmune diseases, and carcinogenesis. Thus, extensive research is being conducted to identify new miRNAs. The growth of the miRNA sequencing and assay market is mainly attributed to the factors such widening range of miRNA applications and rise in funding for genomics research. However, challenges related to delivery, efficacy, and specificity of miRNA-based therapeutics is projected to deter the market growth.

    Lucrative Regionsfor miRNA Sequencing And Assay Market


    Lucrative Regionsfor miRNA Sequencing And Assay Market

    Get more information on this report :


    Market Insights

    Widening Range of MicroRNA Applications

    miRNAs are a group of non-coding and small RNA molecules of 20–30-nucleotide length. These molecules bind to a target messenger RNA (mRNA) and lead to gene silencing, thereby controlling gene expression. Thus, they play a critical role in cell physiology and development. miRNAs regulate all cellular functions such as cell proliferation, differentiation, and apoptosis. Being involved in the process of differentiation, they play a crucial role in offering tissue identity. Hence, miRNAs are thought to be a useful marker in identifying cell types.

    Further, miRNAs are also associated with pathological processes such as viral infections, autoimmune diseases, and carcinogenesis. A few of them can act as oncogenes (oncomiRs), while several other act as tumor suppressor miRNAs. The altered expression of miRNAs is correlated with the occurrence of different types of cancer. The potential of miRNAs, combined with next-generation sequencing technologies, as a new class of cancer biomarkers is being explored. They are predicted to have a vital role to play in assessing development, progression, prognosis, diagnosis, and treatment of cancer. Moreover, several classes of miRNAs have also emerged as promising biomarkers for infectious diseases caused by pathogens, including HIV, Hendra virus, tuberculosis, and malaria.

    Furthermore, discovery regarding the role of miRNAs in disease development have made miRNAs a key target of novel therapeutic approaches. Several miRNA-targeted therapeutics against the diseases such as cancer and hepatitis have reached the clinical phase. For instance, Santaris Pharma has developed a therapeutic molecule named Miravirsen that targets miR-122 for the treatment of hepatitis C virus (HCV) infection; the molecule is in the Phase II clinical trial. Therefore, the growing range of applications of miRNAs is driving the growth of the miRNA sequencing and assay market.

    Product-Based Insights

    The miRNA sequencing and assay market, by product, is segmented into library preparation and consumables. The consumables segment held a larger share of the market in 2019, whereas the library preparation segment is anticipated to register a higher CAGR in the market during the forecast period.

    miRNA Sequencing and Assay Market, by Product – 2019 and 2027

    miRNA Sequencing and Assay Market, by Product – 2019 and 2027

    Get more information on this report :


    Technology-Based Insights

    Based on technology, the miRNA sequencing and assay market is segmented into sequencing by synthesis, nanopore, and ion semiconductor sequencing. The sequencing by synthesis segment held the largest share of the market in 2019; however, the nanopore segment is expected to register the highest CAGR in the market during 2020–2027.

    End User-Based Insights

    Based on end user, the miRNA sequencing and assay market is segmented into research institute, academia, and CROs. The research institute segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during 2020–2027.

    Strategic Insights

    Collaboration is one of the major strategies adopted by the miRNA sequencing and assay market players to enlarge customer base worldwide, which also permits them to maintain their brand name globally.

    miRNA Sequencing and Assay Market – by Product

    • Library Preparation
    • Consumables

    miRNA Sequencing And Assay Market – by Technology

    • Sequencing by Synthesis
    • Nanopore
    • Ion Semiconductor Sequencing

    miRNA Sequencing and Assay Market – by End User

    • Research Institute
    • Academia
    • CRO

    miRNA Sequencing and Assay Market – by Geography

    • North America
      • US
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • UK
      • Spain
      • Rest of Europe
    • Asia Pacific (APAC)
      • China
      • India
      • South Korea
      • Japan
      • Australia
      • Rest of Asia Pacific
    • Middle East and Africa (MEA)
      • South Africa
      • Saudi Arabia
      • UAE
      • Rest of Middle East and Africa
    • South and Central America
      • Brazil
      • Argentina
      • Rest of South and Central America

    Company Profiles

    • Illumina Inc.
    • Thermo Fisher Scientific Inc.
    • Qiagen
    • Perkin Elmer Inc.
    • Takara Bio Inc.
    • New England Biolabs
    • NorgenBiotek Corp
    • TriLinkBioTechnologies Inc
    • Lexogen GmbH
    • Oxford Nanopore Technologies

    1. Introduction

    1.1 Scope of the Study

    1.2 The Insight Partners Research Report Guidance

    1.3 Market Segmentation

    1.3.1 Global miRNA Sequencing And Assay Market – By Product

    1.3.2 Global miRNA Sequencing And Assay Market – By Technology

    1.3.3 Global miRNA Sequencing And Assay Market – By End User

    1.3.4 Global miRNA Sequencing And Assay market – By Geography

    2. miRNA Sequencing And Assay Market – Key Takeaways

    3. Research Methodology

    3.1 Coverage

    3.2 Secondary Research

    3.3 Primary Research

    4. Global miRNA Sequencing And Assay – Market Landscape

    4.1 Overview

    4.2 PEST Analysis

    4.2.1 North America – PEST Analysis

    4.2.2 Europe – PEST Analysis

    4.2.3 Asia Pacific – PEST Analysis

    4.2.4 Middle East and Africa (MEA) – PEST Analysis

    4.2.5 South and Central America (SCAM) – PEST Analysis

    4.3 Expert Opinions

    5. miRNA Sequencing And Assay Market – Key Market Dynamics

    5.1 Key Market Drivers

    5.1.1 Widening Range of MicroRNA Applications

    5.1.2 Rise in Funding for Genomics Research

    5.2 Market Restraints

    5.2.1 Challenges Related to Delivery, Efficacy, and Specificity of miRNA-based Therapeutics

    5.3 Market Opportunities

    5.3.1 Rising Prevalence of Chronic Conditions and Infectious Diseases

    5.4 Future Trends

    5.4.1 Development and Launch of Innovative Products

    5.5 Impact analysis

    6. miRNA Sequencing And Assay Market – Global Analysis

    6.1 Global miRNA Sequencing And Assay Market Revenue Forecast And Analysis

    6.2 Global miRNA Sequencing And Assay Market, By Geography - Forecast And Analysis

    6.3 Market Positioning of Key Players

    7. miRNA Sequencing and Assay Market Analysis – By Product

    7.1 Overview

    7.2 miRNA Sequencing and Assay Market Revenue Share, by Product (2019 and 2027)

    7.3 Library Preparation

    7.3.1 Overview

    7.3.2 Library Preparation: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

    7.4 Consumables

    7.4.1 Overview

    7.4.2 Consumables: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

    8. miRNA Sequencing and Assay Market Analysis – By Technology

    8.1 Overview

    8.2 miRNA Sequencing and Assay Market Share, by Technology, 2019 and 2027, (%)

    8.3 Sequencing By Synthesis

    8.3.1 Overview

    8.3.2 Sequencing By Synthesis: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

    8.4 Nanopore

    8.4.1 Overview

    8.4.2 Nanopore: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

    8.5 Ion Semiconductor Sequencing

    8.5.1 Overview

    8.5.2 Ion Semiconductor Sequencing: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

    9. miRNA Sequencing and Assay Market Analysis – By End User

    9.1 Overview

    9.2 miRNA Sequencing and Assay Market Share, by End User, 2019 and 2027, (%)

    9.3 Research Institute

    9.3.1 Overview

    9.3.2 Research Institute: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

    9.4 Academia

    9.4.1 Overview

    9.4.2 Academia: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

    9.5 Contract Research Organizations (CROs)

    9.5.1 Overview

    9.5.2 Contract Research Organizations (CROs): miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

    10. miRNA Sequencing And Assay Market – Geographic Analysis

    10.1 North America: miRNA Sequencing And Assay Market

    10.1.1 Overview

    10.1.2 North America: miRNA Sequencing And Assay Market – Revenue and Forecast to 2027 (USD Million)

    10.1.3 North America: miRNA Sequencing And Assay Market, by Product, 2018–2027 (USD Million)

    10.1.4 North America: miRNA Sequencing And Assay Market, by Technology, 2018–2027 (USD Million)

    10.1.5 North America: miRNA Sequencing And Assay Market, by End User, 2018–2027 (USD Million)

    10.1.6 North America: miRNA Sequencing And Assay Market, by Country, 2019 & 2027 (%)

    10.1.7 US: miRNA Sequencing And Assay Market – Revenue and Forecast to 2027 (USD Million)

    10.1.7.1 US: miRNA Sequencing And Assay Market – Revenue and Forecast to 2027 (USD Million)

    10.1.7.2 US: miRNA Sequencing And Assay Market, by Product, 2018–2027 (USD Million)

    10.1.7.3 US: miRNA Sequencing And Assay Market, by Technology, 2018–2027 (USD Million)

    10.1.7.4 US: miRNA Sequencing And Assay Market, by End User, 2018–2027 (USD Million)

    10.1.8 Canada: miRNA Sequencing And Assay Market – Revenue and Forecast to 2027 (USD Million)

    10.1.8.1 Canada: miRNA Sequencing And Assay Market – Revenue and Forecast to 2027 (USD Million)

    10.1.8.2 Canada: miRNA Sequencing And Assay Market, by Product, 2018–2027 (USD Million)

    10.1.8.3 Canada miRNA Sequencing And Assay Market, by Technology, 2018–2027 (USD Million)

    10.1.8.4 Canada: miRNA Sequencing And Assay Market, by End User, 2018–2027 (USD Million)

    10.1.9 Mexico: miRNA Sequencing And Assay Market – Revenue and Forecast to 2027 (USD Million)

    10.1.9.1 Mexico: miRNA Sequencing And Assay Market – Revenue and Forecast to 2027 (USD Million)

    10.1.9.2 Mexico: miRNA Sequencing And Assay Market, by Product, 2018–2027 (USD Million)

    10.1.9.3 Mexico: miRNA Sequencing And Assay Market, by Technology, 2018–2027 (USD Million)

    10.1.9.4 Mexico: miRNA Sequencing And Assay Market, by End User, 2018–2027 (USD Million)

    10.2 Europe: miRNA Sequencing And Assay Market

    10.2.1 Overview

    10.2.2 Europe: miRNA Sequencing And Assay Market - Revenue and Forecast to 2027 (USD Million)

    10.2.3 Europe miRNA Sequencing And Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

    10.2.4 Europe miRNA Sequencing And Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    10.2.5 Europe miRNA Sequencing And Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

    10.2.6 Europe: miRNA Sequencing And Assay Market, by Country, 2019 & 2027 (%)

    10.2.7 Germany: miRNA Sequencing And Assay Market – Revenue and Forecast to 2027 (USD Million)

    10.2.7.1 Germany: miRNA Sequencing And Assay Market – Revenue and Forecast to 2027 (USD Million)

    10.2.7.2 Germany miRNA Sequencing And Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

    10.2.7.3 Germany miRNA Sequencing And Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    10.2.7.4 Germany miRNA Sequencing And Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

    10.2.8 UK: miRNA Sequencing And Assay Market – Revenue and Forecast to 2027 (USD Million)

    10.2.8.1 UK: miRNA Sequencing And Assay Market – Revenue and Forecast to 2027 (USD Million)

    10.2.8.2 UK miRNA Sequencing And Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

    10.2.8.3 UK miRNA Sequencing And Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    10.2.8.4 UK miRNA Sequencing And Assay Market, by End User– Revenue and Forecast to 2027 (USD Million)

    10.2.9 France: Market – Revenue and Forecast to 2027 (USD Million)

    10.2.9.1 France: miRNA Sequencing And Assay Market – Revenue and Forecast to 2027 (USD Million)

    10.2.9.2 France miRNA Sequencing And Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

    10.2.9.3 France miRNA Sequencing And Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    10.2.9.4 France miRNA Sequencing And Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

    10.2.10 Spain: miRNA Sequencing And Assay Market – Revenue and Forecast to 2027 (USD Million)

    10.2.10.1 Spain: miRNA Sequencing And Assay Market – Revenue and Forecast to 2027 (USD Million)

    10.2.10.2 Spain miRNA Sequencing And Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

    10.2.10.3 Spain miRNA Sequencing And Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    10.2.10.4 Spain miRNA Sequencing And Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

    10.2.11 Italy: miRNA Sequencing And Assay Market – Revenue and Forecast to 2027 (USD Million)

    10.2.11.1 Italy: miRNA Sequencing And Assay Market – Revenue and Forecast to 2027 (USD Million)

    10.2.11.2 Italy miRNA Sequencing And Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

    10.2.11.3 Italy miRNA Sequencing And Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    10.2.11.4 Italy miRNA Sequencing And Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

    10.2.12 Rest of Europe: miRNA Sequencing And Assay Market – Revenue and Forecast to 2027 (USD Million)

    10.2.12.1 Rest of Europe: miRNA Sequencing And Assay Market – Revenue and Forecast to 2027 (USD Million)

    10.2.12.2 Rest of Europe miRNA Sequencing And Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

    10.2.12.3 Rest of Europe miRNA Sequencing And Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    10.2.12.4 Rest of Europe miRNA Sequencing And Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

    10.3 Asia Pacific: miRNA Sequencing and Assay Market

    10.3.1 Overview

    10.3.2 Asia Pacific: miRNA Sequencing and Assay Market - Revenue and Forecast to 2027 (USD Million)

    10.3.3 Asia Pacific: miRNA Sequencing and Assay Market, by Product, 2018–2027 (USD Million)

    10.3.4 Asia Pacific: miRNA Sequencing and Assay Market, by Technology, 2018–2027 (USD Million)

    10.3.5 Asia Pacific: miRNA Sequencing and Assay Market, by End User, 2018–2027 (USD Million)

    10.3.6 Asia Pacific: miRNA Sequencing and Assay Market, by Country, 2019 & 2027 (%)

    10.3.7 China: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

    10.3.7.1 China: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

    10.3.7.2 China: miRNA Sequencing and Assay Market, by Product, 2018–2027 (USD Million)

    10.3.7.3 China: miRNA Sequencing and Assay Market, by Technology, 2018–2027 (USD Million)

    10.3.7.4 China miRNA Sequencing and Assay Market, by End User, 2018–2027 (USD Million)

    10.3.8 Japan: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

    10.3.8.1 Japan: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

    10.3.8.2 Japan: miRNA Sequencing and Assay Market, by Product, 2018–2027 (USD Million)

    10.3.8.3 Japan: miRNA Sequencing and Assay Market, by Technology, 2018–2027 (USD Million)

    10.3.8.4 Japan miRNA Sequencing and Assay Market, by End User, 2018–2027 (USD Million)

    10.3.9 India: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

    10.3.9.1 India: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

    10.3.9.2 India: miRNA Sequencing and Assay Market, by Product, 2018–2027 (USD Million)

    10.3.9.3 India: miRNA Sequencing and Assay Market, by Technology, 2018–2027 (USD Million)

    10.3.9.4 India miRNA Sequencing and Assay Market, by End User, 2018–2027 (USD Million)

    10.3.10 South Korea: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

    10.3.10.1 South Korea: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

    10.3.10.2 South Korea: miRNA Sequencing and Assay Market, by Product, 2018–2027 (USD Million)

    10.3.10.3 South Korea: miRNA Sequencing and Assay Market, by Technology, 2018–2027 (USD Million)

    10.3.10.4 South Korea miRNA Sequencing and Assay Market, by End User, 2018–2027 (USD Million)

    10.3.11 Australia: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

    10.3.11.1 Australia: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

    10.3.11.2 Australia: miRNA Sequencing and Assay Market, by Product, 2018–2027 (USD Million)

    10.3.11.3 Australia: miRNA Sequencing and Assay Market, by Technology, 2018–2027 (USD Million)

    10.3.11.4 Australia miRNA Sequencing and Assay Market, by End User, 2018–2027 (USD Million)

    10.3.12 Rest of Asia Pacific: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

    10.3.12.1 Rest of Asia Pacific: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

    10.3.12.2 Rest of Asia Pacific: miRNA Sequencing and Assay Market, by Product, 2018–2027 (USD Million)

    10.3.12.3 Rest of Asia Pacific: miRNA Sequencing and Assay Market, by Technology, 2018–2027 (USD Million)

    10.3.12.4 Rest of Asia Pacific miRNA Sequencing and Assay Market, by End User, 2018–2027 (USD Million)

    10.4 Middle East & Africa: miRNA Sequencing and Assay Market

    10.4.1 Overview

    10.4.2 Middle East & Africa: miRNA Sequencing and Assay Market - Revenue and Forecast to 2027 (US$ Million)

    10.4.3 Middle East & Africa: miRNA Sequencing and Assay Market, by Product, 2018–2027 (USD Million)

    10.4.4 Middle East & Africa miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    10.4.5 Middle East & Africa miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

    10.4.6 Middle East & Africa: miRNA Sequencing and Assay Market, by Country, 2019 & 2027 (%)

    10.4.7 Saudi Arabia: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

    10.4.7.1 Saudi Arabia: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

    10.4.7.2 Saudi Arabia: miRNA Sequencing and Assay Market, by Product, 2018–2027 (USD Million)

    10.4.7.3 Saudi Arabia miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    10.4.7.4 Saudi Arabia miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

    10.4.8 UAE: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

    10.4.8.1 UAE: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

    10.4.8.2 UAE: miRNA Sequencing and Assay Market, by Product, 2018–2027 (USD Million)

    10.4.8.3 UAE miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    10.4.8.4 UAE miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

    10.4.9 South Africa: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

    10.4.9.1 South Africa: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

    10.4.9.2 South Africa: miRNA Sequencing and Assay Market, by Product, 2018–2027 (USD Million)

    10.4.9.3 South Africa miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    10.4.9.4 South Africa miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

    10.4.10 Rest of Middle East and Africa: miRNA Sequencing and Assay Market - Revenue and Forecasts to 2027 (USD Million)

    10.4.10.1 Rest of Middle East and Africa: miRNA Sequencing and Assay Market - Revenue and Forecasts to 2027 (USD Million)

    10.4.10.2 Rest of Middle East and Africa: miRNA Sequencing and Assay Market, by Product, 2018–2027 (USD Million)

    10.4.10.3 Rest of Middle East and Africa miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    10.4.10.4 Rest of Middle East and Africa miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

    10.5 South and Central America: miRNA sequencing and assay Market

    10.5.1 Overview

    10.5.2 South and Central America: miRNA sequencing and assay Market – Revenue and Forecast to 2027 (USD Million)

    10.5.3 South and Central America: miRNA sequencing and assay Market, by Product, 2018–2027 (USD Million)

    10.5.4 South and Central America: miRNA sequencing and assay Market, by Technology 2018–2027 (USD Million)

    10.5.5 South and Central America: miRNA sequencing and assay Market, by End User, 2018–2027 (USD Million)

    10.5.6 South and Central America: miRNA sequencing and assay Market, by Country, 2019 & 2027 (%)

    10.5.7 Brazil: miRNA sequencing and assay Market – Revenue and Forecast to 2027 (USD Million)

    10.5.7.1 Brazil: miRNA sequencing and assay Market – Revenue and Forecast to 2027 (USD Million)

    10.5.7.2 Brazil: miRNA sequencing and assay Market, by Product, 2018–2027 (USD Million)

    10.5.7.3 Brazil: miRNA sequencing and assay Market, by Technology 2018–2027 (USD Million)

    10.5.7.4 Brazil: miRNA sequencing and assay Market, by End User, 2018–2027 (USD Million)

    10.5.8 Argentina: miRNA sequencing and assay Market – Revenue and Forecast to 2027 (USD Million)

    10.5.8.1 Argentina: miRNA sequencing and assay Market – Revenue and Forecast to 2027 (USD Million)

    10.5.8.2 Argentina: miRNA sequencing and assay Market, by Product, 2018–2027 (USD Million)

    10.5.8.3 Argentina: miRNA sequencing and assay Market, by Technology 2018–2027 (USD Million)

    10.5.8.4 Argentina: miRNA sequencing and assay Market, by End User, 2018–2027 (USD Million)

    10.5.9 Rest of South and Central America: miRNA sequencing and assay Market – Revenue and Forecast to 2027 (USD Million)

    10.5.9.1 Rest of South and Central America: miRNA sequencing and assay Market – Revenue and Forecast to 2027 (USD Million)

    10.5.9.2 Rest of South and Central America: miRNA sequencing and assay Market, by Product, 2018–2027 (USD Million)

    10.5.9.3 Rest of South and Central America: miRNA sequencing and assay Market, by Technology 2018–2027 (USD Million)

    10.5.9.4 Rest of South and Central America: miRNA sequencing and assay Market, by End User, 2018–2027 (USD Million)

    11. Impact of COVID-19 Pandemic on Global miRNA Sequencing and Assay Market

    11.1 North America: Impact Assessment of COVID-19 Pandemic

    11.2 Europe: Impact Assessment of COVID-19 Pandemic

    11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

    11.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic

    11.5 South & Central America: Impact Assessment of COVID-19 Pandemic

    12. Industry Landscape

    12.1 Overview

    12.2 Growth Strategies Done by the Companies in the Market, (%)

    12.3 Organic Developments

    12.3.1 Overview

    12.4 Inorganic Developments

    12.4.1 Overview

    13. Company Profiles

    13.1 Illumina, Inc.

    13.1.1 Key Facts

    13.1.2 Business Description

    13.1.3 Products and Services

    13.1.4 Financial Overview

    13.1.5 SWOT Analysis

    13.1.6 Key Developments

    13.2 THERMO FISHER SCIENTIFIC INC.

    13.2.1 Key Facts

    13.2.2 Business Description

    13.2.3 Products and Services

    13.2.4 Financial Overview

    13.2.5 SWOT Analysis

    13.2.6 Key Developments

    13.3 QIAGEN

    13.3.1 Key Facts

    13.3.2 Business Description

    13.3.3 Products and Services

    13.3.4 Financial Overview

    13.3.5 SWOT Analysis

    13.3.6 Key Developments

    13.4 Perkin Elmer, Inc.

    13.4.1 Key Facts

    13.4.2 Business Description

    13.4.3 Products and Services

    13.4.4 Financial Overview

    13.4.5 SWOT Analysis

    13.4.6 Key Developments

    13.5 Takara Bio Inc.

    13.5.1 Key Facts

    13.5.2 Business Description

    13.5.3 Products and Services

    13.5.4 Financial Overview

    13.5.5 SWOT Analysis

    13.5.6 Key Developments

    13.6 New England Biolabs

    13.6.1 Key Facts

    13.6.2 Business Description

    13.6.3 Products and Services

    13.6.4 Financial Overview

    13.6.5 SWOT Analysis

    13.6.6 Key Developments

    13.7 Norgen Biotek Corp

    13.7.1 Key Facts

    13.7.2 Business Description

    13.7.3 Products and Services

    13.7.4 Financial Overview

    13.7.5 SWOT Analysis

    13.7.6 Key Developments

    13.8 TriLink BioTechnologies Inc.

    13.8.1 Key Facts

    13.8.2 Business Description

    13.8.3 Products and Services

    13.8.4 Financial Overview

    13.8.5 SWOT Analysis

    13.8.6 Key Developments

    13.9 Lexogen GmbH

    13.9.1 Key Facts

    13.9.2 Business Description

    13.9.3 Products and Services

    13.9.4 Financial Overview

    13.9.5 SWOT Analysis

    13.9.6 Key Developments

    13.10 Oxford Nanopore Technologies

    13.10.1 Key Facts

    13.10.2 Business Description

    13.10.3 Products and Services

    13.10.4 Financial Overview

    13.10.5 SWOT Analysis

    13.10.6 Key Developments

    14. Appendix

    14.1 About The Insight Partners

    14.2 Glossary of Terms

    LIST OF TABLES

    Table 1. North America miRNA Sequencing And Assay Market, by Product– Revenue and Forecast to 2027 (USD Million)

    Table 2. North America miRNA Sequencing And Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 3. North America miRNA Sequencing And Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

    Table 4. US miRNA Sequencing And Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 5. US miRNA Sequencing And Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 6. US miRNA Sequencing And Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

    Table 7. Canada miRNA Sequencing And Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 8. Canada miRNA Sequencing And Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 9. Canada miRNA Sequencing And Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

    Table 10. Mexico miRNA Sequencing And Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 11. Mexico miRNA Sequencing And Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 12. Mexico miRNA Sequencing And Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

    Table 13. Europe miRNA Sequencing And Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 14. Europe miRNA Sequencing And Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 15. Europe miRNA Sequencing And Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

    Table 16. Germany miRNA Sequencing And Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 17. Germany miRNA Sequencing And Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 18. Germany miRNA Sequencing And Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

    Table 19. UK miRNA Sequencing And Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 20. UK miRNA Sequencing And Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 21. UK: miRNA Sequencing And Assay Market, by End User – Revenue and Forecast to 2027 (USD Million).

    Table 22. France miRNA Sequencing And Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 23. France miRNA Sequencing And Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 24. France miRNA Sequencing And Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

    Table 25. Spain miRNA Sequencing And Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 26. Spain miRNA Sequencing And Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 27. Spain miRNA Sequencing And Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

    Table 28. Italy miRNA Sequencing And Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 29. Italy miRNA Sequencing And Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 30. Italy miRNA Sequencing And Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

    Table 31. Rest of Europe miRNA Sequencing And Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 32. Rest of Europe miRNA Sequencing And Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 33. Rest of Europe miRNA Sequencing And Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

    Table 34. Asia Pacific miRNA Sequencing and Assay Market, by Product– Revenue and Forecast to 2027 (USD Million)

    Table 35. Asia Pacific miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 36. Asia Pacific miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

    Table 37. China miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 38. China miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 39. China miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

    Table 40. Japan miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 41. Japan miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 42. Japan miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

    Table 43. India miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 44. India miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 45. India miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

    Table 46. South Korea miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 47. South Korea miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 48. South Korea miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

    Table 49. Australia miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 50. Australia miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 51. Australia miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

    Table 52. Rest of Asia Pacific miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 53. Rest of Asia Pacific miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 54. Rest of Asia Pacific miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

    Table 55. Middle East & Africa miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 56. Middle East & Africa miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 57. Middle East & Africa miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

    Table 58. Saudi Arabia miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 59. Saudi Arabia miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 60. Saudi Arabia miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

    Table 61. UAE miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 62. UAE miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 63. UAE miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

    Table 64. South Africa miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 65. South Africa miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 66. South Africa miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

    Table 67. Rest of Middle East and Africa miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 68. Rest of Middle East and Africa miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 69. Rest of Middle East and Africa miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

    Table 70. South and Central America miRNA sequencing and assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 71. South and Central America miRNA sequencing and assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 72. South and Central America miRNA sequencing and assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

    Table 73. Brazil miRNA sequencing and assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 74. Brazil miRNA sequencing and assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 75. Brazil miRNA sequencing and assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

    Table 76. Argentina miRNA sequencing and assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 77. Argentina miRNA sequencing and assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 78. Argentina miRNA sequencing and assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

    Table 79. Rest of South and Central America miRNA sequencing and assay Market, by Product – Revenue and Forecast to 2027 (USD Million)

    Table 80. Rest of South and Central America miRNA sequencing and assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)

    Table 81. Rest of South and Central America miRNA sequencing and assay Market, by End User – Revenue and Forecast to 2027 (USD Million)

    Table 82. Organic Developments Done By Companies

    Table 83. Inorganic Developments Done By Companies

    Table 84. Glossary of Terms, miRNA Sequencing And Assay Market

    LIST OF FIGURES

    Figure 1. miRNA Sequencing And Assay Market Segmentation

    Figure 2. miRNA Sequencing And Assay Market Segmentation, By Region

    Figure 3. miRNA Sequencing And Assay Market Overview

    Figure 4. Library Preparation Segment by Product Segment Expected to Witness Rapid Growth

    Figure 5. APAC to Show Significant Growth During Forecast Period

    Figure 6. miRNA Sequencing And Assay Market, by Geography (US$ Million)

    Figure 7. Global miRNA Sequencing And Assay Market – Leading Country Markets (US$ Million)

    Figure 8. Global miRNA Sequencing And Assay Market, Industry Landscape

    Figure 9. North America PEST Analysis

    Figure 10. Europe PEST Analysis

    Figure 11. Asia Pacific PEST Analysis

    Figure 12. Middle East and Africa (MEA) PEST Analysis

    Figure 13. South and Central America (SCAM) PEST Analysis

    Figure 14. miRNA Sequencing and Assay Market Impact Analysis of Driver and Restraints

    Figure 15. Global miRNA Sequencing And Assay Market – Revenue Forecast And Analysis – 2019- 2027

    Figure 16. Global miRNA Sequencing And Assay Market – By Geography Forecast and Analysis – 2019- 2027

    Figure 17. Market Positioning Of Key Players In Global miRNA Sequencing And Assay Market

    Figure 18. miRNA Sequencing and Assay Market Revenue Share, by Product (2019 and 2027)

    Figure 19. Library Preparation: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 20. Consumables: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 21. miRNA Sequencing and Assay Market Share, by Technology, 2019 and 2027 (%)

    Figure 22. Sequencing By Synthesis: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 23. Nanopore: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 24. Ion Semiconductor Sequencing: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 25. miRNA Sequencing and Assay Market Share, by End User, 2019 and 2027 (%)

    Figure 26. Research Institute: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 27. Academia: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 28. Contract Research Organizations (CROs): miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 29. North America: miRNA Sequencing And Assay Market, by Key Country – Revenue (2019) (USD Million)

    Figure 30. North America miRNA Sequencing And Assay Market Revenue and Forecast to 2027 (USD Million)

    Figure 31. North America: miRNA Sequencing And Assay Market, by Country, 2019 & 2027 (%)

    Figure 32. US: miRNA Sequencing And Assay Market – Revenue and Forecast to 2027 (USD Million)

    Figure 33. Canada: miRNA Sequencing And Assay Market – Revenue and Forecast to 2027 (USD Million)

    Figure 34. Mexico: miRNA Sequencing And Assay Market – Revenue and Forecast to 2027 (USD Million)

    Figure 35. Europe: miRNA Sequencing And Assay Market, by Key Country – Revenue (2019) (USD Million)

    Figure 36. Europe miRNA Sequencing And Assay Market Revenue and Forecast to 2027 (USD Million)

    Figure 37. Europe: miRNA Sequencing And Assay Market, by Country, 2019 & 2027 (%)

    Figure 38. Germany: miRNA Sequencing And Assay Market – Revenue and Forecast to 2027 (USD Million)

    Figure 39. UK: miRNA Sequencing And Assay Market – Revenue and Forecast to 2027 (USD Million)

    Figure 40. France: miRNA Sequencing And Assay Market – Revenue and Forecast to 2027 (USD Million)

    Figure 41. Spain: miRNA Sequencing And Assay Market – Revenue and Forecast to 2027 (USD Million)

    Figure 42. Italy: miRNA Sequencing And Assay Market – Revenue and Forecast to 2027 (USD Million)

    Figure 43. Rest of Europe: miRNA Sequencing And Assay Market – Revenue and Forecast to 2027 (USD Million)

    Figure 44. Asia Pacific: miRNA Sequencing and Assay Market, by Key Country – Revenue (2019) (USD Million)

    Figure 45. Asia Pacific miRNA Sequencing and Assay Market Revenue and Forecast to 2027 (USD Million)

    Figure 46. Asia Pacific: miRNA Sequencing and Assay Market, by Country, 2019 & 2027 (%)

    Figure 47. China: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

    Figure 48. Japan: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

    Figure 49. India: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

    Figure 50. South Korea: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

    Figure 51. Australia: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

    Figure 52. Rest of Asia Pacific: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

    Figure 53. Middle East & Africa: miRNA Sequencing and Assay Market, by Key Country – Revenue (2019) (USD Million)

    Figure 54. Middle East & Africa miRNA Sequencing and Assay Market Revenue and Forecast to 2027 (USD Million)

    Figure 55. Middle East & Africa: miRNA Sequencing and Assay Market, by Country, 2019 & 2027 (%)

    Figure 56. Saudi Arabia: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

    Figure 57. UAE: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

    Figure 58. South Africa: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)

    Figure 59. Rest of Middle East and Africa: miRNA Sequencing and Assay Market - Revenue And Forecasts To 2027 (USD Million)

    Figure 60. South and Central America: miRNA sequencing and assay Market, by Key Country – Revenue (2019) (USD Million)

    Figure 61. South and Central America miRNA sequencing and assay Market Revenue and Forecast to 2027 (USD Million)

    Figure 62. South and Central America: miRNA sequencing and assay Market, by Country, 2019 & 2027 (%)

    Figure 63. Brazil: miRNA sequencing and assay Market – Revenue and Forecast to 2027 (USD Million)

    Figure 64. Argentina: miRNA sequencing and assay Market – Revenue and Forecast to 2027 (USD Million)

    Figure 65. Rest of South and Central America: miRNA sequencing and assay Market – Revenue and Forecast to 2027 (USD Million)

    Figure 66. Impact of COVID-19 Pandemic in North American Country Markets

    Figure 67. Impact of COVID-19 Pandemic in European Country Markets

    Figure 68. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

    Figure 69. Impact of COVID-19 Pandemic in Middle East & Africa Market

    Figure 70. Impact of COVID-19 Pandemic in South & Central America Market

    Figure 71. Growth Strategies Done by the Companies in the Market, (%)

    The List of Companies - MiRNA Sequencing And Assay Market

    1. Illumina Inc.
    2. Thermo Fisher Scientific Inc.
    3. Qiagen
    4. Perkin Elmer Inc.
    5. Takara Bio Inc.
    6. New England Biolabs
    7. NorgenBiotek Corp
    8. TriLinkBioTechnologies Inc
    9. Lexogen GmbH
    10. Oxford Nanopore Technologies
    • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the miRNA sequencing and assay market.
    • Highlights key business priorities in order to assist companies to realign their business strategies.
    • The key findings and recommendations highlight crucial progressive industry trends in the global miRNA sequencing and assay market, thereby allowing players across the value chain to develop effective long-term strategies.
    • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
    • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
    • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
    TIPRE00006960
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Get the Latest COVID-19 Analysis on this market



    Frequently Asked Questions

    miRNA is a small non-coding RNA molecule of 20–30-nucleotide length, and it plays an important role in gene regulation. As it is partially complementary to messenger RNA (mRNA), it serves a major function of down-regulating the gene expression, which makes it a key controller of important cellular functions. miRNAs are associated with pathological processes such as viral infections, autoimmune diseases, and carcinogenesis. Thus, extensive research is being conducted to identify new miRNAs.
    The growth of the miRNA sequencing and assay market is mainly attributed to the factors such widening range of miRNA applications and rise in funding for genomics research. However, challenges related to delivery, efficacy, and specificity of miRNA-based therapeutics is projected to deter the market growth.
    The GMP cytokines market majorly consists of the players such as Illumina, Inc., Thermo Fisher Scientific Inc., Qiagen, Perkin Elmer, Inc., Takara Bio Inc., New England Biolabs, Norgen Biotek Corp, TriLink BioTechnologies Inc, Lexogen GmbH, and Oxford Nanopore Technologies among others.

    Pricing
    • $3000
    • $4550
    • $6550
    • $8550

        GET FREE SAMPLE PDF

    Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

        Inquire for Discount   Speak to Analyst